Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
13 Cards in this Set
- Front
- Back
|
International Headache Society Classification: Primary Headache
|
-Tension headache
-Cluster headaches -Migraine headaches |
|
|
International Headache Society Classification: Secondary Headache
|
-Organic disorders:
-Hemorrhage -Infection -Stroke -Tumor |
|
|
Primary Headache: Tension headache
|
-bilateral
-band-like pressure -dental, cervical, visual corrections |
|
|
Primary Headace: Cluster headaches
|
-unilateral
-behind eye -15 min to 3 hrs -0.5% of population |
|
|
Migraine: Elements (?)
|
-Triggers (stress, anxiety, hormones, chocolate)
-Disorder of cranial blood vessels -Involvement of 5HT and/or NE -May involve glutamate, NO, histamine sensitivities -Trigeminal nerve (V) sensory afferents |
|
|
Migraine: Phases
|
-Premonitory
-Aura -Headache -Postdrome |
|
|
Migraine: Premonitory phase
|
-60%
-hrs/days -psychological, sensory or autonomic |
|
|
Migraine: Aura phase
|
-20%
-visual, sensory, motor, language disturbances |
|
|
Migraine: Headache phase
|
-4 to 72 hrs
-photophobia, phonophobia, sensory stimulation |
|
|
Migraine: Postdrome phase
|
-up to 24 hrs
-euphoric, depressed, irritability |
|
|
Migraine: Neurogenic model
|
-neuronal dysfunction w/subsequent vascular changes
-release of vasoactive neuropeptides: -Sub P -Calcitonin gene related peptide -Neurokinin A causing vasodilation -Plasma extravasation -Mast cell degranulation -Neurogenic inflammation -Ascending projections of trigeminal nerve activate thalamic pain centers -Facial nerve (VII) activated |
|
|
Migraine: Acute treatment (Mild to Moderate)
|
-Oral analgesics (Aspirin, NSAIDS, Acetaminophen)
-Ketorolac: -stronger NSAID -IM or oral -decrease pain, nausea, photophobia -Antiemetic agents -chloropromazine -metoclopromide -promethazine |
|
|
Migraine: Actue treatment (Moderate to Severe)
|
-Ergots
-vasoconstrictors -Ergotamine tartrate (oral or suppository) -Dihydroergotamine (IM or nasal spray) -Triptans -Opiates -MOA: -activate 5HT 1D/1B -activate presynaptic 5HT 1D/1B receptors |
